Wednesday - April 22, 2026

Category Archives: Pharmaceuticals & Biotech

Cernum Biosciences Peptide Store Recognized in Independent Review for Transparency and Quality

Cernum Biosciences review 2026 highlights peptide purity testing, transparency standards, and third-party verification in research compounds Cernum Biosciences has been recognized in a 2026 independent review for its quality standards, transparency, and overall customer confidence in the peptide space. The … Continue reading →

Ibogaine by David Dardashti Aligns with New Federal”Right to Try” Directives to Target the NeurologicalRoots of Childhood Trauma

MIAMI, FL – April 20, 2026 – Following the recent Executive Order to fast-track access to investigational psychedelics, Ibogaine by David Dardashti announces a renewed focus on advanced clinical insights for treating the neurological impact of severe childhood trauma. As … Continue reading →

Pulmonary Hypertension associated Interstitial Lung Disease Market Size (7MM) was ~USD 3 Billion in 2025 and is projected to expand at a CAGR of 3.9% through 2036, estimates DelveInsight

DelveInsight’s “Pulmonary Hypertension associated Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding of the Pulmonary Hypertension associated Interstitial Lung Disease, historical and forecasted epidemiology and the Pulmonary Hypertension associated Interstitial Lung Disease … Continue reading →

Familial Chylomicronemia Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Familial Chylomicronemia Syndrome Pipeline Insights 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Familial Chylomicronemia Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Metastatic Colorectal Cancer Treatment Clinical Trial Pipeline Shows Potential with Active Contributions from 150+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Lupus Nephritis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Lupus Nephritis Pipeline Insight 2026” report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Lupus Nephritis pipeline landscape. It covers the Lupus Nephritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Endometriosis Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the Endometriosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Endometriosis Pipeline therapeutics … Continue reading →

Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research

A renewed spotlight is forming around a group of small-cap healthcare companies as U.S. policy shifts toward accelerating research into psychedelic-based therapies for mental health disorders. Following a recent executive order aimed at expanding research pathways, companies below are drawing … Continue reading →

CRISPR Market Set to Reach $5.47 Billion by 2030 Amid Surge in Gene Editing Applications and Biotech Investments

CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030 According to MarketsandMarkets™, the CRISPR market is projected to grow from … Continue reading →